These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15527218)

  • 41. The treatment of urinary incontinence with Duloxetine.
    Basu M; Duckett J
    J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duloxetine-induced cutaneous adverse reaction.
    Oulis P; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kouzoupis AV; Soldatos CR
    J Clin Psychopharmacol; 2008 Feb; 28(1):104-5. PubMed ID: 18204353
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder.
    Brecht S; Kajdasz D; Ball S; Thase ME
    Int Clin Psychopharmacol; 2008 Nov; 23(6):317-24. PubMed ID: 18854719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duloxetine treatment of Premenstrual Dysphoric Disorder: case reports.
    Ramos MG; Hara C; Rocha FL
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):579-80. PubMed ID: 17897763
    [No Abstract]   [Full Text] [Related]  

  • 45. [A challenge].
    Krankenpfl J; 2005; 43(4-6):93. PubMed ID: 16171044
    [No Abstract]   [Full Text] [Related]  

  • 46. Manic switching in patients receiving duloxetine.
    de Dios C; Ezquiaga E
    Am J Psychiatry; 2007 Jul; 164(7):1121. PubMed ID: 17606669
    [No Abstract]   [Full Text] [Related]  

  • 47. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
    Jost W; Marsalek P
    Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Duloxetine treatment of social anxiety disorder with comorbid major depression.
    Lin CC
    J Clin Psychopharmacol; 2008 Oct; 28(5):591-2; author reply 592-3. PubMed ID: 18794669
    [No Abstract]   [Full Text] [Related]  

  • 49. Serotonin-norepinephrine reuptake inhibitor treatment for tinnitus and depression.
    Chang JP; Wu CC
    J Clin Psychopharmacol; 2012 Oct; 32(5):729. PubMed ID: 22926618
    [No Abstract]   [Full Text] [Related]  

  • 50. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
    Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA
    J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful duloxetine treatment of a binge eating disorder: a case report.
    Bernardi S; Pallanti S
    J Psychopharmacol; 2010 Aug; 24(8):1269-72. PubMed ID: 19010975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cymbalta (duloxetine) in the treatment of anxiety-depressive disorders in patients with discirculatory encephalopathy].
    Rzheusskaia GV; Listopadov IuI; Bobrova MV; Umrudina AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(2):26-30. PubMed ID: 19365368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Stress incontinence in general practice].
    Krankenpfl J; 2004; 42(7-10):228-9. PubMed ID: 15675390
    [No Abstract]   [Full Text] [Related]  

  • 54. [Psycho- and pharmacotherapy of depressions. So you combine correctly].
    Arnheim K
    MMW Fortschr Med; 2009 May; 151(19):20. PubMed ID: 19827439
    [No Abstract]   [Full Text] [Related]  

  • 55. An open-label study of duloxetine hydrochloride, a mixed serotonin and noradrenaline reuptake inhibitor, in patients with DSM-III-R major depressive disorder. Lilly Duloxetine Depression Study Group.
    Berk M; du Plessis AD; Birkett M; Richardt D
    Int Clin Psychopharmacol; 1997 May; 12(3):137-40. PubMed ID: 9248869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The development of new antidepressants: focus on duloxetine and escitalopram.
    Huffman JC; Perlis RH
    Harv Rev Psychiatry; 2003; 11(1):30-6. PubMed ID: 12866739
    [No Abstract]   [Full Text] [Related]  

  • 57. SNRIs in the management of acute major depressive disorder.
    Zajecka JM; Albano D
    J Clin Psychiatry; 2004; 65 Suppl 17():11-8. PubMed ID: 15600377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study.
    Solaro C; Bergamaschi R; Rezzani C; Mueller M; Trabucco E; Bargiggia V; Dematteis F; Mattioda A; Cimino V; Restivo D; Patti F; Cavalla P
    Clin Neuropharmacol; 2013; 36(4):114-6. PubMed ID: 23783007
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duloxetine: a review of its pharmacology and use in chronic pain management.
    Bellingham GA; Peng PW
    Reg Anesth Pain Med; 2010; 35(3):294-303. PubMed ID: 20921842
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia.
    Arnold LM
    Pain Med; 2007 Sep; 8 Suppl 2():S63-74. PubMed ID: 17714117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.